James M Weaver insider trades: Interleukin Genetics (ILIU) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where James reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 29, 2016 | ILIU | ↑ Buy | 100,603 | $0.10 | $10K | Indirect | Aug 1, 2016 (3d) |
| Dec 30, 2005 | XRIT | ↑ Buy | 153 | $8.50 | $1K | Direct | Jan 3, 2006 (4d) |
| Sep 30, 2005 | XRIT | ↑ Buy | 123 | $10.54 | $1K | Direct | Oct 3, 2005 (3d) |
| Jul 1, 2005 | XRIT | ↑ Buy | 133 | $9.85 | $1K | Direct | Jul 5, 2005 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About James M Weaver's insider trades
James M Weaver is a director at Interleukin Genetics (ILIU). Since Jul 1, 2005, James has reported 4 open-market purchases worth $14K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (7 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ILIU insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.